biotech · Rheumatoid Arthritis · Pharmacokinetics · XBIT
XBiotech Germany
XBiotech Germany GmbH
BBT Biotech is a biotech organization headquartered in Baesweiler, DE. It trades on NYSE under ticker XBIT. Primary therapeutic focus areas include Rheumatoid Arthritis, Pharmacokinetics, Staphylococcus Aureus Bacteremia
Baesweiler, DE HQ
30 Employees
Public company Type
XBIT · NYSE Ticker
Company details
- Status
- Public
- HQ
- Baesweiler, DE
- Employees
- 30
- Programs
- 8
- Drugs
- 6
- Patents
- 31
514G3 (2 mg/kg) plus standard IV antibiotic treatment
Phase 2 · mab · Staphylococcus Aureus Bacteremia
514G3 (2 mg/kg) plus standard IV antibiotic treatment for Staphylococcus Aureus Bacteremia is a Phase 2 program (mab) at XBiotech Germany GmbH with 1 ClinicalTrials.gov record(s).
Internal code 2014-PT029
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- XBiotech Germany GmbH
- Phase
- Phase 2
- Modality
- mab
- Indication
- Staphylococcus Aureus Bacteremia
- Status
- completed
- Trials
- 1